BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28645286)

  • 1. The myths surrounding mild stimulation in vitro fertilization (IVF).
    Orvieto R; Vanni VS; Gleicher N
    Reprod Biol Endocrinol; 2017 Jun; 15(1):48. PubMed ID: 28645286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].
    Yu R; Lin J; Zhao JZ; Wang PY; Xiao SQ; Zhang W
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):250-4. PubMed ID: 22781109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CHALLENGING THE OPTIMAL NUMBER OF RETRIEVED OOCYTES AND ITS IMPACT ON PREGNANCY AND LIVE BIRTH RATES IN IVF/ICSI CYCLES].
    Blais I; Lahav-Baratz S; Koifman M; Wiener-Megnazi Z; Auslender R; Dirnfeld M
    Harefuah; 2015 Jun; 154(6):350-5, 406. PubMed ID: 26281076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficiency of mild ovarian stimulation with clomiphene on poor ovarian responders during IVF\ICSI procedures: a meta-analysis.
    Song D; Shi Y; Zhong Y; Meng Q; Hou S; Li H
    Eur J Obstet Gynecol Reprod Biol; 2016 Sep; 204():36-43. PubMed ID: 27521596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assisted reproductive techniques.
    Huang JY; Rosenwaks Z
    Methods Mol Biol; 2014; 1154():171-231. PubMed ID: 24782010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high number of oocytes obtained after ovarian hyperstimulation for in vitro fertilization or intracytoplasmic sperm injection is not associated with decreased pregnancy outcome.
    Kok JD; Looman CW; Weima SM; te Velde ER
    Fertil Steril; 2006 Apr; 85(4):918-24. PubMed ID: 16580375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles.
    Kuang Y; Hong Q; Chen Q; Lyu Q; Ai A; Fu Y; Shoham Z
    Fertil Steril; 2014 Jan; 101(1):105-11. PubMed ID: 24161646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios.
    Groen H; Tonch N; Simons AH; van der Veen F; Hoek A; Land JA
    Hum Reprod; 2013 Dec; 28(12):3236-46. PubMed ID: 24166594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is IVF-served two different ways-more cost-effective than IUI with controlled ovarian hyperstimulation?
    Tjon-Kon-Fat RI; Bensdorp AJ; Bossuyt PM; Koks C; Oosterhuis GJ; Hoek A; Hompes P; Broekmans FJ; Verhoeve HR; de Bruin JP; van Golde R; Repping S; Cohlen BJ; Lambers MD; van Bommel PF; Slappendel E; Perquin D; Smeenk J; Pelinck MJ; Gianotten J; Hoozemans DA; Maas JW; Groen H; Eijkemans MJ; van der Veen F; Mol BW; van Wely M
    Hum Reprod; 2015 Oct; 30(10):2331-9. PubMed ID: 26269539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome.
    Das M; Son WY; Buckett W; Tulandi T; Holzer H
    Reprod Biomed Online; 2014 Nov; 29(5):545-51. PubMed ID: 25262236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild stimulation for in vitro fertilization.
    Nargund G; Datta AK; Fauser BCJM
    Fertil Steril; 2017 Oct; 108(4):558-567. PubMed ID: 28965549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal stimulation IVF vs conventional IVF: a randomized controlled trial.
    Zhang JJ; Merhi Z; Yang M; Bodri D; Chavez-Badiola A; Repping S; van Wely M
    Am J Obstet Gynecol; 2016 Jan; 214(1):96.e1-8. PubMed ID: 26259908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GnRH-agonist ovulation trigger in patients undergoing controlled ovarian hyperstimulation for IVF with ultrashort flare GnRH-agonist combined with multidose GnRH-antagonist protocol.
    Orvieto R; Nahum R; Zohav E; Liberty G; Anteby EY; Meltcer S
    Gynecol Endocrinol; 2013 Jan; 29(1):51-3. PubMed ID: 22857268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIVET rFSH dosing algorithms for individualized controlled ovarian stimulation enables optimized pregnancy productivity rates and avoidance of ovarian hyperstimulation syndrome.
    Yovich JL; Alsbjerg B; Conceicao JL; Hinchliffe PM; Keane KN
    Drug Des Devel Ther; 2016; 10():2561-73. PubMed ID: 27563236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].
    Zhu YM; Gao HJ; He RH; Huang HF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):740-4. PubMed ID: 17327030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro fertilization at a public hospital in Nigeria.
    Orhue AA; Aziken ME; Osemwenkha AP; Ibadin KO; Odoma G
    Int J Gynaecol Obstet; 2012 Jul; 118(1):56-60. PubMed ID: 22503520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oocyte quality in patients with severe ovarian hyperstimulation syndrome: a self-controlled clinical study.
    Fábregues F; Peñarrubia J; Vidal E; Casals G; Vanrell JA; Balasch J
    Fertil Steril; 2004 Oct; 82(4):827-33. PubMed ID: 15482755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.